Teleflex Incorporated (NYSE:TFX) Shares Purchased by Confluence Wealth Services Inc.

Confluence Wealth Services Inc. grew its stake in shares of Teleflex Incorporated (NYSE:TFX) by 39.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,410 shares of the medical technology company’s stock after acquiring an additional 400 shares during the period. Confluence Wealth Services Inc.’s holdings in Teleflex were worth $255,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of TFX. Northwestern Mutual Wealth Management Co. lifted its position in shares of Teleflex by 19.8% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 484 shares of the medical technology company’s stock valued at $102,000 after acquiring an additional 80 shares during the period. Sanctuary Advisors LLC acquired a new stake in shares of Teleflex during the 2nd quarter valued at approximately $918,000. Czech National Bank lifted its position in shares of Teleflex by 6.9% during the 3rd quarter. Czech National Bank now owns 9,598 shares of the medical technology company’s stock valued at $2,374,000 after acquiring an additional 623 shares during the period. GAMMA Investing LLC lifted its position in shares of Teleflex by 131.1% during the 3rd quarter. GAMMA Investing LLC now owns 171 shares of the medical technology company’s stock valued at $42,000 after acquiring an additional 97 shares during the period. Finally, Fulton Bank N.A. lifted its position in shares of Teleflex by 14.6% during the 3rd quarter. Fulton Bank N.A. now owns 1,229 shares of the medical technology company’s stock valued at $304,000 after acquiring an additional 157 shares during the period. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

TFX has been the subject of a number of research reports. Truist Financial reduced their price target on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a research report on Wednesday, December 18th. Mizuho dropped their price objective on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research note on Friday, November 1st. Royal Bank of Canada dropped their price objective on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. StockNews.com raised shares of Teleflex from a “hold” rating to a “buy” rating in a research note on Thursday, November 28th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat, Teleflex has a consensus rating of “Moderate Buy” and an average target price of $252.50.

Teleflex Stock Down 1.4 %

TFX stock opened at $173.61 on Friday. The stock has a market capitalization of $8.06 billion, a P/E ratio of 34.51, a PEG ratio of 1.78 and a beta of 1.16. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. Teleflex Incorporated has a one year low of $171.69 and a one year high of $256.85. The company has a 50 day moving average price of $180.84 and a two-hundred day moving average price of $211.88.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.